Top Markets
Coin of the day
Mydecine Innovations Group Inc. Mydecine Innovations Group Inc.

Mydecine Innovations Group Inc.

MYCO
Hisse Senetlerindeki Sıralama #30738
Mydecine Innovations Group Inc. is a biotechnology and life sciences enterprise... Mydecine Innovations Group Inc. is a biotechnology and life sciences enterprise dedicated to advancing and commercializing therapies for a range of mental health conditions. The company specializes in developing treatments for specific populations, including veterans, emergency medical service providers, frontline workers, and individuals affected by post-traumatic stress disorder. It also operates Mindleap, an online telehealth platform offering mental wellness services and support for psychedelic integration, including aftercare. Furthermore, Mydecine engages in drug discovery, developing nature-derived psychedelic-assisted therapeutics, novel compounds, specific therapy protocols, and unique drug delivery systems. The company also manages a hemp cultivation facility in Pottus, Texas. Strategic collaborations include alliances with Leiden University Medical Center, Royal Ottawa Mental Health Centre, and LeadGen Labs for psychedelic drug development, as well as Applied Pharmaceutical Innovation for drug development and clinical trial programs. Founded in 2013, the company, originally known as NewLeaf Brands Inc., rebranded as Mydecine Innovations Group Inc. in June 2020 and is headquartered in Vancouver, Canada.
Hisse Fiyatı
$0.25687791
Son senkronizasyon: 2026-01-13
Piyasa Değeri
$15.72M
Değişim (1 gün)
100.54%
Değişim (1 yıl)
6,975.98%
Ülke
CA
Ticaret Mydecine Innovations Group Inc. (MYCO)

Kategori

Mydecine Innovations Group Inc. (MYCO) için temettü verimi geçmişi
Mydecine Innovations Group Inc. (hisse sembolü: MYCO) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
Mydecine Innovations Group Inc. (MYCO) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)